1. Home
  2. VRA vs CUE Comparison

VRA vs CUE Comparison

Compare VRA & CUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vera Bradley Inc.

VRA

Vera Bradley Inc.

HOLD

Current Price

$3.46

Market Cap

94.5M

ML Signal

HOLD

Logo Cue Biopharma Inc.

CUE

Cue Biopharma Inc.

HOLD

Current Price

$0.27

Market Cap

27.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VRA
CUE
Founded
1982
2014
Country
United States
United States
Employees
1725
41
Industry
Apparel
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
94.5M
27.8M
IPO Year
2010
2017

Fundamental Metrics

Financial Performance
Metric
VRA
CUE
Price
$3.46
$0.27
Analyst Decision
Hold
Strong Buy
Analyst Count
2
2
Target Price
N/A
$3.00
AVG Volume (30 Days)
386.6K
442.9K
Earning Date
06-11-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
35.14
EPS
N/A
N/A
Revenue
$416,097,000.00
$9,287,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$1.61
$25.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
69.16
52 Week Low
$1.39
$0.23
52 Week High
$3.60
$1.05

Technical Indicators

Market Signals
Indicator
VRA
CUE
Relative Strength Index (RSI) 69.12 39.65
Support Level $1.93 $0.27
Resistance Level N/A $0.36
Average True Range (ATR) 0.20 0.03
MACD 0.07 0.00
Stochastic Oscillator 82.69 14.60

Price Performance

Historical Comparison
VRA
CUE

About VRA Vera Bradley Inc.

Vera Bradley Inc designs women's handbags, travel items, and accessories. Each category comprises a substantial component of total sales, with the bags category comprising the majority of the company's sales are made directly to customers through Vera Bradley's retail stores and e-commerce sites. The company also has a substantial wholesale business selling to specialty retail and department stores. Almost all company sales are in the United States. Vera Bradley uses third-party manufacturers in Asia to produce its products, and the company distributes the products through its distribution center in Indiana. The Company has three reportable segments: Vera Bradley Direct, Vera Bradley Indirect, and Pura Vida. The majority of revenue is from the Vera Bradley Direct segment.

About CUE Cue Biopharma Inc.

Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.

Share on Social Networks: